• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发胃癌及其淋巴转移配对类器官可用于个体化医疗。

Paired organoids from primary gastric cancer and lymphatic metastasis are useful for personalized medicine.

机构信息

Department of General Surgery of Ruijin Hospital, Shanghai Institute of Digestive Surgery, Shanghai Key Laboratory for Gastric Neoplasms, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Shanghai Engineering Center for Molecular Medicine, Zhangjiang, Shanghai, 200120, China.

出版信息

J Transl Med. 2024 Aug 12;22(1):754. doi: 10.1186/s12967-024-05512-0.

DOI:10.1186/s12967-024-05512-0
PMID:39135062
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11318189/
Abstract

BACKGROUND

Organoids are approved by the US FDA as an alternative to animal experiments to guide drug development and for sensitivity screening. Stable organoids models of gastric cancer are desirable for personalized medicine and drug screening.

METHODS

Tumor tissues from a primary cancer of the stomach and metastatic cancer of the lymph node were collected for 3D culture. By long-term culture for over 50 generations in vitro, we obtained stably growing organoid lines. We analyzed short tandem repeats (STRs) and karyotypes of cancer cells, and tumorigenesis of the organoids in nude mice, as well as multi-omics profiles of the organoids. A CCK8 method was used to determine the drugs sensitivity to fluorouracil (5-Fu), platinum and paclitaxel.

RESULTS

Paired organoid lines from primary cancer (SPDO1P) and metastatic lymph node (SPDO1LM) were established with unique STRs and karyotypes. The organoid lines resulted in tumorigenesis in vivo and had clear genetic profiles. Compared to SPDO1P from primary cancer, upregulated genes of SPDO1LM from the metastatic lymph node were enriched in pathways of epithelial-mesenchymal transition and angiogenesis with stronger abilities of cell migration, invasion, and pro-angiogenesis. Based on drug sensitivity analysis, the SOX regimen (5-Fu plus oxaliplatin) was used for chemotherapy with an optimal clinical outcome.

CONCLUSIONS

The organoid lines recapitulate the drug sensitivity of the parental tissues. The paired organoid lines present a step-change toward living biobanks for further translational usage.

摘要

背景

类器官已获得美国食品和药物管理局批准,可作为替代动物实验的方法,用于指导药物开发和敏感性筛选。胃癌稳定的类器官模型对于个性化医疗和药物筛选是理想的。

方法

从胃原发癌和淋巴结转移癌的肿瘤组织中进行 3D 培养。通过体外长期培养超过 50 代,我们获得了稳定生长的类器官系。我们分析了癌细胞的短串联重复序列(STR)和核型,以及裸鼠中的类器官肿瘤发生情况,以及类器官的多组学图谱。使用 CCK8 法测定氟尿嘧啶(5-Fu)、铂类和紫杉醇对类器官的药物敏感性。

结果

建立了配对的原发癌(SPDO1P)和转移性淋巴结(SPDO1LM)类器官系,具有独特的 STR 和核型。类器官系在体内导致肿瘤发生,并具有明确的遗传特征。与原发癌的 SPDO1P 相比,转移性淋巴结的 SPDO1LM 上调基因富集在上皮-间充质转化和血管生成途径中,具有更强的细胞迁移、侵袭和促血管生成能力。基于药物敏感性分析,采用 SOX 方案(5-Fu 加奥沙利铂)进行化疗,取得了最佳的临床效果。

结论

类器官系再现了亲本组织的药物敏感性。配对的类器官系为进一步转化应用提供了活体生物库的重大进展。

相似文献

1
Paired organoids from primary gastric cancer and lymphatic metastasis are useful for personalized medicine.原发胃癌及其淋巴转移配对类器官可用于个体化医疗。
J Transl Med. 2024 Aug 12;22(1):754. doi: 10.1186/s12967-024-05512-0.
2
PI3 expression predicts recurrence after chemotherapy with DNA-damaging drugs in gastric cancer.PI3表达可预测胃癌患者接受DNA损伤药物化疗后的复发情况。
J Pathol. 2025 Apr;265(4):472-485. doi: 10.1002/path.6400. Epub 2025 Feb 20.
3
Chemotherapy for advanced gastric cancer.晚期胃癌的化疗
Cochrane Database Syst Rev. 2017 Aug 29;8(8):CD004064. doi: 10.1002/14651858.CD004064.pub4.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
High-Throughput Drug Screening of Clear Cell Ovarian Cancer Organoids Reveals Vulnerability to Proteasome Inhibitors and Dinaciclib and Identifies AGR2 as a Therapeutic Target.透明细胞卵巢癌类器官的高通量药物筛选揭示了对蛋白酶体抑制剂和地西他滨的敏感性,并确定AGR2为治疗靶点。
Cancer Res Commun. 2025 Jun 1;5(6):1018-1033. doi: 10.1158/2767-9764.CRC-25-0024.
6
Patient-derived tumor organoids highlight the potential of precision medicine in managing pancreatic ductal adenocarcinoma.患者来源的肿瘤类器官凸显了精准医学在治疗胰腺导管腺癌方面的潜力。
Int J Cancer. 2025 Aug 15;157(4):760-772. doi: 10.1002/ijc.35443. Epub 2025 Apr 28.
7
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
8
Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study.赞布替尼联合化疗作为HER2阳性晚期胃食管腺癌患者的一线治疗:一项多中心、单臂、2期研究的主要结果
Lancet Oncol. 2025 May 30. doi: 10.1016/S1470-2045(25)00287-6.
9
Anti-cancer drug sensitivity testing and preclinical evaluation of the anti-cancer potential of WEE1 inhibitor in triple-negative breast cancer patient-derived organoids and xenograft models.在三阴性乳腺癌患者来源的类器官和异种移植模型中进行抗癌药物敏感性测试以及WEE1抑制剂抗癌潜力的临床前评估。
Breast Cancer Res. 2025 Jun 23;27(1):113. doi: 10.1186/s13058-025-02063-0.
10
The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.伊立替康、奥沙利铂和雷替曲塞用于治疗晚期结直肠癌:系统评价与经济学评估
Health Technol Assess. 2008 May;12(15):iii-ix, xi-162. doi: 10.3310/hta12150.

引用本文的文献

1
Factors associated with actionable gene aberrations in pancreatic cancer based on the C-CAT database.基于C-CAT数据库的胰腺癌中与可操作基因畸变相关的因素。
J Gastroenterol. 2025 May 2. doi: 10.1007/s00535-025-02253-9.
2
The application of organoids in investigating immune evasion in the microenvironment of gastric cancer and screening novel drug candidates.类器官在研究胃癌微环境中的免疫逃逸及筛选新型候选药物中的应用。
Mol Cancer. 2025 Apr 26;24(1):125. doi: 10.1186/s12943-025-02328-4.
3
Organoids as Sophisticated Tools for Renal Cancer Research: Extensive Applications and Promising Prospects.

本文引用的文献

1
Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis.丙氨酰-tRNA 合成酶,AARS1,是一种乳酸感应器和乳酰基转移酶,它可以乳酰化 p53 并促进肿瘤发生。
Cell. 2024 May 9;187(10):2375-2392.e33. doi: 10.1016/j.cell.2024.04.002. Epub 2024 Apr 22.
2
Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression.肠上皮化生的时空基因组分析揭示了胃癌进展的克隆动力学。
Cancer Cell. 2023 Dec 11;41(12):2019-2037.e8. doi: 10.1016/j.ccell.2023.10.004. Epub 2023 Oct 26.
3
Evaluation of Pathological Response Rate and Complications of FOLFOX versus FLOT Regimen in Perioperative Chemotherapy for Resectable Gastric Cancer: A Prospective Study.
类器官作为肾癌研究的精密工具:广泛应用与广阔前景
Cell Mol Bioeng. 2024 Oct 15;17(6):527-548. doi: 10.1007/s12195-024-00825-y. eCollection 2024 Dec.
4
Standard: Human gastric organoids.标准:人胃类器官。
Cell Regen. 2025 Jan 14;14(1):2. doi: 10.1186/s13619-024-00218-6.
5
Standard: Human gastric cancer organoids.标准:人胃癌类器官。
Cell Regen. 2024 Dec 27;13(1):33. doi: 10.1186/s13619-024-00217-7.
6
Living biobank: Standardization of organoid construction and challenges.活体生物样本库:类器官构建的标准化及挑战
Chin Med J (Engl). 2024 Dec 20;137(24):3050-3060. doi: 10.1097/CM9.0000000000003414. Epub 2024 Dec 12.
FOLFOX 方案与 FLOT 方案用于可切除胃癌围手术期化疗的病理缓解率和并发症评估:一项前瞻性研究。
Asian Pac J Cancer Prev. 2023 Aug 1;24(8):2791-2797. doi: 10.31557/APJCP.2023.24.8.2791.
4
Genomic and evolutionary characteristics of metastatic gastric cancer by routes.通过途径分析转移性胃癌的基因组和进化特征。
Br J Cancer. 2023 Sep;129(4):672-682. doi: 10.1038/s41416-023-02338-3. Epub 2023 Jul 8.
5
A quick and reliable image-based AI algorithm for evaluating cellular senescence of gastric organoids.一种快速可靠的基于图像的 AI 算法,用于评估胃类器官的细胞衰老。
Cancer Biol Med. 2023 Jun 30;20(7):519-36. doi: 10.20892/j.issn.2095-3941.2023.0099.
6
Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing.胃癌患者来源的类器官培养用于疾病建模和药物敏感性测试。
Biomed Pharmacother. 2023 Jul;163:114751. doi: 10.1016/j.biopha.2023.114751. Epub 2023 Apr 26.
7
Analysis of the efficacy and influencing factors of preoperative P-SOX neoadjuvant chemotherapy regimen for progressive gastric cancer-construction of a clinical prediction model.术前 P-SOX 新辅助化疗方案治疗进展期胃癌的疗效及影响因素分析-临床预测模型的构建。
Cancer Med. 2023 Jun;12(12):13031-13040. doi: 10.1002/cam4.5977. Epub 2023 Apr 25.
8
Patient-derived organoids in translational oncology and drug screening.转化肿瘤学与药物筛选中的患者来源类器官
Cancer Lett. 2023 May 28;562:216180. doi: 10.1016/j.canlet.2023.216180. Epub 2023 Apr 13.
9
Neutrophils promote tumor invasion FAM3C-mediated epithelial-to-mesenchymal transition in gastric cancer.中性粒细胞通过 FAM3C 介导的上皮-间充质转化促进胃癌的侵袭。
Int J Biol Sci. 2023 Feb 21;19(5):1352-1368. doi: 10.7150/ijbs.79022. eCollection 2023.
10
Efficacy and safety of FLOT regimen DCF, FOLFOX, and ECF regimens as perioperative chemotherapy treatments for resectable gastric cancer patients; a report from the middle east.FLOT方案、DCF方案、FOLFOX方案和ECF方案作为可切除胃癌患者围手术期化疗治疗的疗效和安全性:来自中东的报告。
Res Pharm Sci. 2022 Oct 29;17(6):621-634. doi: 10.4103/1735-5362.359430. eCollection 2022 Dec.